U-Ik Jang
Fortune : 672 462 $ au 31/05/2026
Fortune : 672 462 $ au 31/05/2026
U-Ik Jang is currently Co-Chief Executive Officer at YBiologics, Inc. and Co-Chief Executive Officer & Director at Y-Biologics, Inc. Former positions include Non-Executive Director at Genexine, Inc., Independent Director at Atinum Investment Co., Ltd. from 2019 to 2025, and Vice President & Head-Handok Central Research at Handok, Inc. from 2011 to 2014.
Education includes graduate and doctorate degrees from Yonsei University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Y-BIOLOGICS INC. 0,39 % | 09/04/2026 | 60 000 ( 0,39 % ) | 672 462 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| Y-BIOLOGICS, INC. | Directeur Général | 15/09/2022 |
YBiologics, Inc.
YBiologics, Inc. BiotechnologyHealth Technology Develops medical treatments and pharmaceuticals | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ATINUM INVESTMENT CO., LTD | Directeur/Membre du Conseil | 19/03/2025 |
| GENEXINE, INC. | Directeur/Membre du Conseil | 30/03/2015 |
| HANDOK INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Handok, Inc.
Handok, Inc. Pharmaceuticals: OtherHealth Technology Manufactures botanical medicines | Health Technology |
Atinum Investment Co., Ltd.
Atinum Investment Co., Ltd. Investment ManagersFinance Invests in venture and startup businesses | Finance |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genexine, Inc.
Genexine, Inc. BiotechnologyHealth Technology Engages in the research and development of bio-pharmaceuticals | Health Technology |
YBiologics, Inc.
YBiologics, Inc. BiotechnologyHealth Technology Develops medical treatments and pharmaceuticals | Health Technology |
Y-Biologics, Inc.
Y-Biologics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company that specializes in the research and development of novel antibody therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national